Table 5.
Multivariate regression results of post-operative mortality and neurological complications.
Characteristics | B | P-value | OR value | OR 95%CI |
---|---|---|---|---|
Short-term prognosis | ||||
Permanent neurological complications | ||||
Hybrid surgery | 1.668 | <0.001 | 5.304 | 2.120–13.271 |
Diabetes | 1.145 | 0.042 | 3.141 | 1.043–9.458 |
Mortality during hospitalization | ||||
Coronary artery disease | 1.219 | 0.042 | 3.384 | 1.048–10.930 |
Ascending aorta replacement surgery | −2.189 | 0.001 | 0.112 | 0.030–0.425 |
LVEF (%) | −0.052 | 0.046 | 0.949 | 0.902–0.999 |
Platelet (109/L) | −0.010 | 0.007 | 0.990 | 0.982–0.997 |
Long-term prognosis | ||||
Neurological complications | ||||
Hybrid surgery | 1.756 | <0.001 | 5.791 | 2.087–16.067 |
Coronary artery disease | 1.315 | 0.044 | 3.723 | 1.033–13.416 |
All-cause mortality | B | P -value | HR value | HR 95%CI |
Previous cerebrovascular disease | 1.574 | <0.001 | 4.825 | 2.382–9.775 |
Previous cardiac surgery | 0.925 | 0.024 | 2.522 | 1.127–5.644 |
Emergency surgery | 1.016 | <0.001 | 2.761 | 1.652–4.615 |
Combined CABG surgery | 1.094 | <0.001 | 2.985 | 1.565–5.692 |
LVEF, Left Ventricular Ejection Fraction; CABG, Coronary Artery Bypass Graft; OR, Odds Ratio; HR, Hazard Ratio. The variables considered in the multivariate regression analysis included surgery method, gender, age, onset within 14 days, BMI, hypertension, coronary artery disease, diabetes, chronic respiratory disease, renal insufficiency, previous cerebrovascular disease, smoking history, previous cardiac surgery, LVEF, absolute value of erythrocyte, absolute value of leukocyte, platelets, emergency surgery, ascending aorta replacement surgery, CABG, cardiopulmonary bypass time, aortic cross-clamp time.